Academic literature on the topic 'Immune-related adverse effects (irAEs)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Immune-related adverse effects (irAEs).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Immune-related adverse effects (irAEs)"
Naing, Aung, Joud Hajjar, James L. Gulley, Michael B. Atkins, Gennaro Ciliberto, Funda Meric-Bernstam, and Patrick Hwu. "Strategies for improving the management of immune-related adverse events." Journal for ImmunoTherapy of Cancer 8, no. 2 (December 2020): e001754. http://dx.doi.org/10.1136/jitc-2020-001754.
Full textReynolds, Kerry Lynn, Justine Vanessa Cohen, Sienna Durbin, Molly Thomas, Michael Dougan, Holly S. Martinson, Alex Faje, et al. "Inpatient admissions related to immune-related adverse effects (irAE) among patients treated with immune checkpoint inhibitors for advanced malignancy: A tsunami is coming, but are we ready?" Journal of Clinical Oncology 36, no. 5_suppl (February 10, 2018): 127. http://dx.doi.org/10.1200/jco.2018.36.5_suppl.127.
Full textChen, Ru, Min Zhou, and Feng Zhu. "Immune Checkpoint Inhibitors Related to Cardiotoxicity." Journal of Cardiovascular Development and Disease 9, no. 11 (November 3, 2022): 378. http://dx.doi.org/10.3390/jcdd9110378.
Full textKawahira, Machiko, Shuji Kanmura, Keiko Mizuno, Kentaro Machida, Takao Ohtsuka, Masami Sato, Hideki Enokida, et al. "Effects of immune checkpoint inhibitor therapy resumption in patients with malignant tumors after moderate-to-severe immune-related adverse events." PLOS ONE 17, no. 4 (April 28, 2022): e0267572. http://dx.doi.org/10.1371/journal.pone.0267572.
Full textWang, QuanQiu, and Rong Xu. "Immunotherapy-related adverse events (irAEs): extraction from FDA drug labels and comparative analysis." JAMIA Open 2, no. 1 (October 15, 2018): 173–78. http://dx.doi.org/10.1093/jamiaopen/ooy045.
Full textCoschi, Courtney H., and Rosalyn A. Juergens. "The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer." Current Oncology 28, no. 6 (November 2, 2021): 4392–407. http://dx.doi.org/10.3390/curroncol28060373.
Full textThapa, Bicky, Joanna Roopkumar, Ann S. Kim, Lorenzo Gervaso, Pradnya Dinkar Patil, Cassandra Calabrese, Alok A. Khorana, and Pauline Funchain. "Incidence and clinical pattern of immune related adverse effects (irAE) due to immune checkpoint inhibitors (ICI)." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e14151-e14151. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e14151.
Full textKapoor, Akhil, Vanita Noronha, Vijay Maruti Patil, Amit Joshi, Nandini Sharrel Menon, and Kumar Prabhash. "Association of immune-related adverse effects and survival in responders treated with immune checkpoint inhibitors." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e15172-e15172. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e15172.
Full textRodriguez, Benigno, José Fabián Martínez-Herrera, Lorena López Zepeda, Guillermo Olivares, Alberto Villalobos, Fernando Perez, Christian Patricio Camacho Limas, et al. "Association of immune-related adverse events with immune-checkpoint inhibitors and treatment response in melanoma patients." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): e21522-e21522. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e21522.
Full textKim, Sarah, A. Dimitrios Colevas, Stephanie Tse, Sandy On, and Edna Cheung. "Immune-related adverse effects of long-term PD-1/PD-L1 inhibtor treatment." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 2661. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2661.
Full textBooks on the topic "Immune-related adverse effects (irAEs)"
Drug-induced immune diseases. Amsterdam: Elsevier, 1990.
Find full textImmunotoxicity testing: Methods and protocols. New York, NY: Humana Press, 2010.
Find full textDietert, Rodney R. Immunotoxicity Testing: Methods and Protocols. Humana Press, 2016.
Find full textCoyle, Patricia K. Immune-mediated Disorders of the Central Nervous System. Edited by Emma Ciafaloni, Cheryl Bushnell, and Loralei L. Thornburg. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190667351.003.0010.
Full textBook chapters on the topic "Immune-related adverse effects (irAEs)"
Meara, Alexa Simon, and Leonard H. Calabrese. "Management of Rheumatic Immune-Related Adverse Events (irAEs): General Principles." In Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy, 309–21. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-56824-5_14.
Full textE. Omar, Nabil, Hebatalla M. Afifi, Arwa O. Sahal, Rana Mekkawi, and Hazem Elewa. "The Flip of the Coin of Personalized Cancer Immunotherapy: A Focused Review on Rare Immune Checkpoint Related Adverse Effects." In Immune Checkpoint Inhibitors - New Insights and Recent Progress [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.107833.
Full textRivera-Grana, Erick, and Stephanie M. Llop. "Immunotherapy-Associated Uveitis." In Eye Diseases - Recent Advances, New Perspectives and Therapeutic Options [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.106442.
Full textMoran, Carla. "Endocrine Complications of Biological Cancer Therapies." In Oxford Textbook of Endocrinology and Diabetes 3e, edited by John A. H. Wass, Wiebke Arlt, and Robert K. Semple, 1774–78. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198870197.003.0218.
Full textPatel, Anush, Haisam Abid, and Amrat Kumar. "The Endocrinological Side Effects of Immunotherapies." In Advances in Precision Medicine Oncology. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.96491.
Full textMemis Bilgin, Yavuz. "Clinical Effects and Possible Mechanisms of Transfusion-Related Immunomodulation." In Blood Donation and Transfusion [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.107228.
Full textBhattacharyya, Joya, and Arthur Kaser. "Immune disorders of the gastrointestinal tract." In Oxford Textbook of Medicine, edited by Jack Satsangi, 2783–96. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0292.
Full textBurton, Rosie, and Ana Houston. "HIV medicine." In Oxford Handbook of Tropical Medicine 5e, 69–142. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198810858.003.0003.
Full textMolitch, Mark E., and Jelena Kravarusic. "Lymphocytic Hypophysitis and other Inflammatory Conditions of the Pituitary." In Oxford Textbook of Endocrinology and Diabetes 3e, edited by John A. H. Wass, Wiebke Arlt, and Robert K. Semple, 304–12. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198870197.003.0035.
Full textPerera, Frederica. "A Myriad of Health Impacts from Fossil Fuel." In Children's Health and the Peril of Climate Change, 46—C3.S27. Oxford University PressNew York, 2022. http://dx.doi.org/10.1093/oso/9780197588161.003.0003.
Full textConference papers on the topic "Immune-related adverse effects (irAEs)"
Sklodowski, Kamil, Vito Dozio, Roberta Poli, Andrés Lanzós, Silvia Lopez-Lastra, Kristina Beeler, and Emanuela Romano. "Abstract 1615: Immune-related adverse effects (irAEs) associated proteomic profile in late-stage NSCLC patients after PD-1 blockade." In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1615.
Full textKaakour, Dalia, Matthew Slaught, Armon Azizi, Gianna Kroening, Jennifer Valerin, and Nataliya Mar. "1247 Distribution of immune-related adverse events (irAEs) in solid malignancies." In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.1247.
Full textEnnis, D., F. To, and S. Jamal. "THU0615 Immune related adverse events (IRAES) associated with checkpoint inhibitors: 12 cases from a single centre." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.6009.
Full textLiu, Jing, Stephten J. Blake, Kirsten A. Fairfax, Michelle C. R. Yong, Stacey Allen, Mark J. Smyth, and Michele W. L. Teng. "Abstract B122: A preclinical mouse model to assess antitumor efficacy and development of immune related adverse events (irAEs) following combination immunotherapies." In Abstracts: CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival; September 16-19, 2015; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr15-b122.
Full textDavis, Andrew A., Jonghanne Park, Leeseul Kim, Gahyun Gim, Wade T. Iams, Michael S. Oh, Robert W. Lentz, et al. "Abstract 5527: Serum proteomic scores for understanding the mechanisms of immune-related adverse events (irAEs) in non-small cell lung cancer." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-5527.
Full textRichter, M. D., C. S. Crowson, L. A. Kottschade, H. D. Finnes, S. N. Markovic, and U. Thanarajasingam. "SAT0588 Rheumatologic immune-related adverse effects of checkpoint inhibitor therapy: a single centrecohort of 29 patients." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.2645.
Full textKandolf Sekulović, Lidija. "TOXICITIES OF TARGETED THERAPY AND IMMUNE-RELATED ADVERSE DRUG REACTIONS OF IMMUNOTHERAPY IN THE TREATMENT OF METASTATIC MELANOMA." In Okrugli sto s međunarodnim učešćem "Melanom". Akademija nauka i umjetnosti Bosne i Hercegovine, 2018. http://dx.doi.org/10.5644/pi2019.180.04.
Full textKostine, M., E. Mauric, L. Rouxel, T. Barnetche, R. Veillon, F. Martin, C. Dutriaux, et al. "OP0088 Immune-related adverse events of cancer immunotherapy – when inflammatory side effects are associated with survival: a single-centre prospective cohort study." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.3783.
Full textMONBRUN, Mathilde, Léo Grassion, Elodie Blanchard, Rémi Veillon, Maeva Zysman, and Chantal Raherison. "Influenza and Pneumococcal vaccination effects on the immune-related adverse events in patients under immunotherapy for an advanced stage non-small cell lung cancer." In ERS International Congress 2021 abstracts. European Respiratory Society, 2021. http://dx.doi.org/10.1183/13993003.congress-2021.pa2303.
Full text